Jinsang Sanjie Wan (金嗓散结丸)金嗓散结丸

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

马勃是一种在国家药监局注册认定的药品。该药品含有丹参、木蝴蝶、板蓝根-c934fe08等成分。

该药品关联的活性成分包括:丹参salvia、木蝴蝶Muhu Die、板蓝根Banlan Gen、泽泻Ze Xie、浙贝母Zhebei Mu。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:西安碑林药业股份有限公司Chinese legal name: 西安碑林药业股份有限公司。

您可以探索含有相同成分的其他药品:丹参-d5a58f0e成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 金嗓散结丸) is a medicine registered with the national drug regulatory authority. It contains salvia and other recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 丹参salvia, 木蝴蝶Muhu Die, 板蓝根Banlan Gen, 泽泻Ze Xie, 浙贝母Zhebei Mu.

Manufacturers recorded for this product: 西安碑林药业股份有限公司Chinese legal name: 西安碑林药业股份有限公司.

Explore other medicines containing the same ingredient: 丹参 productssalvia products.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 金嗓散结丸Recorded Chinese name: 金嗓散结丸
  • 剂型Dosage form: 丸剂Pills
  • 规格Specification: 360粒360 capsules

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 西安碑林药业股份有限公司Chinese legal name: 西安碑林药业股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字Z61020814

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字Z61020814

Manufacturer

Chinese legal name: 西安碑林药业股份有限公司 (domestically manufactured)

Traditional functions

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字Z61020814

生产企业

西安碑林药业股份有限公司(国产)

功能主治

清热解毒,活血化瘀,利湿化痰。用于热毒蕴结、气滞血瘀所致的声音嘶哑、声带充血、肿胀;慢性喉炎、声带小结、声带息肉见上述证候者。

用法用量

口服,一日2次,一次60-120粒。

不良反应

尚不明确。

禁忌

尚不明确。

注意事项

尚不明确。

贮藏

密封保存。

规格

360粒

证据Evidence

  • 批准文号: 国药准字Z61020814
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.